Section Arrow
MGX.NASDAQ
- Metagenomi
Quotes are at least 15-min delayed:2025/06/05 15:53 EDT
Last
 1.68
-0.02 (-1.18%)
Day High 
1.74 
Prev. Close
1.7 
1-M High
1.92 
Volume 
225.33K 
Bid
1.67
Ask
1.68
Day Low
1.66 
Open
1.74 
1-M Low
1.4 
Market Cap 
63.55M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.7 
20-SMA 1.64 
50-SMA 1.58 
52-W High 6.9 
52-W Low 1.23 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.85/-2.91
Enterprise Value
103.73M
Balance Sheet
Book Value Per Share
5.69
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
52.30M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NCNANuCana plc0.0394-0.0067-14.53%-- 
CLRBCellectar Biosciences0.3965-0.0652-14.12%-- 
RXRXRecursion Pharmaceuticals4.54-0.37-7.54%-- 
SCNIScinai Immunotherapeutics Ltd.3.03+0.51+20.24%1.21PE
OCGNOcugen0.9446+0.0574+6.47%-- 
Quotes are at least 15-min delayed:2025/06/05 15:53 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.